Research Awards for October 2011
Byerly, Matthew, Columbia Univ./NIH, 2/2: Comparison of Long-Acting Injectable Medication for Schizophrenia (ACLAIMS), $50,000; Byerly, Matthew, Duke Univ./NIH, Comparison of Long-Acting Injectable Medications for Schizophrenia, $45,316; Cadeddu, Jeffrey, UT Arlington/NIH, Transrectal Imaging of Prostate Cancer Using Globally Convergent Method, $49,928; Cadeddu, Jeffrey, UT Arlington/U.S. Dept. of Defense, Development of Hybrid Optical Biopsy Probe to Improve Prostate Cancer Diagnosis, $31,400; Carr, Bruce, NIH, Contraceptive Efficacyacy Evaluation of Path Female Condom, $18,237; Corey, David (K. Gagnon, Fellow), NIH, Activating Gene Expression with Antigene RNAs to Treat Genetic Diseases, $52,154; Cowan, Christopher, Mount Sinai School of Medicine/NIH, Molecular Neurobiology of Drug Addiction-Pj 3, $74,813; Dobbie, Alison, HRSA, Expanded Training in Community Service Learning for Family Medicine Residents, $381,498.
Drazner, Mark, Duke Univ./NIH, STICHES-Surgical Treatment of Ischemic Heart Failure, $1,000; Fitzgerald, John, Duke Univ./NIH, IPF-PANTHER: Idiopathic Pulmonary Fibrosis Clinical Research Network, $4,089; Gruchalla, Rebecca, Univ. of Wisconsin/NIH, Inner City Asthma Consortium (ICAC): Immunologic Approaches to Reduce Asthma - Core Study, $562,315; Gruchalla, Rebecca, Univ. of Wisconsin/NIH, Preventive Omalizumab or Step-Up Therapy for Severe Fall Exacerbations (PROSE), $151,657; Hall, Christiana, Univ. of Cincinnati/NIH, Ethnic/Racial Variation in Intracerebral Hemorrhage (ERICH); Subaward #6883, $212,190; Hall, Christiana, Univ. of Cincinnati/NIH, Recanalization Therapies and Markers of Stroke Outcomes; STOP-IT, $18,994; Idris, Ahamed, Univ. of Washington/NIH, ROC Protocols; PROPHET/BLAST/RESCUE Studies, $228,215; Jain, Mamta, Fred Hutchinson Cancer Research Ctr./NIH, FHCRC HVTN 505 Protocol Site Expansion, $230,971.
Kennard, Beth, UT Dallas/NIH, Neuroimaging Biomarkers of Outcome for Diffuse Axonal Injury, $14,085; Lavery, Lawrence, New York Univ./NIH, Wound EMR to Decrease Limb Amputations in Persons with Diabetes – ARRA Stimulus AHRQ, $192,037; Leitch, Marilyn, Duke Univ./NIH, ACOSOG Administrative Coordinating Ctr.; Site 119, $33,184; Lister, George, NIH, National Children’s Study Centers - Lamar County, $2,635,592; Lu, Hanzhang, Baylor/NIH, Neurobehavioral Outcome of Head Injury in Children, $14,811; MacDonald, Raymond, Vanderbilt Univ./NIH, Architecture and Communication Controlling Efficacyient Generation of Beta Cells; VUMC37153, $332,850; MacDonald, Raymond, Vanderbilt Univ./NIH, Genetic Control of Pancreatic Endocrine Cell Development, $205,000; MacDonald, Raymond, Vanderbilt Univ./NIH, Coordinating Center for Beta Cell Biology Consortium – HIDEF, $71,325; Malter, James, NIH, Pin1 Regulation of Prosurvival Signaling in Eosinophils, $62,709; Malter, James, NIH, Pin1 in Synaptic Plasticity and Translation - ARRA Stimulus Funding, $32,039.
McKnight, Steven, Mount Sinai School of Medicine/NIH, Neural Substrates of Appetitive Behavior in Mood and Motivation - Project IV, $107,170; Nedzi, Lucien, American Coll. Of Radiology/NIH, Radiation Therapy Oncology Group (RTOG); Agmt. #5915, $3,500; Paulk, Mary, Dana-Farber Cancer Inst./NIH, Comprehensive Minority Institution/Cancer Center Partnership, $17,955; Phillips, Margaret, Seattle Biomedical Research Inst./NIH, Genome Wide Assessment of Essential Genes in Trypanosoma Brucei, $19,837; Pride, Glenn, Med. Univ. of South Carolina/NIH, Stenting vs. Aggressive Medical Management for Preventing Recurrent Events in Intracranial Stenosis (SAMMPRIS), $45,569; Punaro, Marilynn, Duke Univ./NIH, CARRANet: Accelerating Toward Evidence Based Culture in Pediatric Rheumatology - ARRA Stimulus Funding, $510; Roland, Peter, Vanderbilt Univ./NIH, Clinical Validation and Testing of Percutaneous Cochlear Implantation, $1,800; Sanchez, Pablo, RTI Intl./NIH, NICHD Neonatal Research Network Capitation Funding, $30,456.
Scheuermann, Richard, Northrop Grumman Corp./NIH, Bioinformatics Resource Center for Infectious Diseases; Virus Pathogen Resource (ViPR), $534,052; Schiller, Joan, Eastern Cooperative Oncology Grp./NIH, ECOG Clinical Trials – Federal Payments, $5,750; Shay, Jerry, Georgetown Univ./NASA, NSCORS: Carcinogenesis and Central Nervous System Risks from Space Radiation – Project 2, $117,750; Shay, Jerry, Georgetown Univ./NASA, NSCORS: Carcinogenesis and Central Nervous System Risks from Space Radiation – Project 1, $117,750; Shay, Jerry, Georgetown Univ./NASA, NSCORS: Carcinogenesis and Central Nervous System Risks from Space Radiation – Project 3, $39,250; Shay, Jerry, Georgetown Univ./NASA, NSCORS: Carcinogenesis and Central Nervous System Risks from Space Radiation – Core B, $8,635; Shay, Jerry, Georgetown Univ./NASA, NSCORS: Carcinogenesis and Central Nervous System Risks from Space Radiation – Core D, $7,850; Shay, Jerry, Georgetown Univ./NASA, NSCORS: Carcinogenesis and Central Nervous System Risks from Space Radiation – Core A, $3,532.
Skapek, Stephen, NIH, ARF Controls Vascular Regression During Eye Development, $91,807; Sweeney, John, Univ. of Georgia/NIH, Neural Mechanisms for Antisaccade Errors Among Schizophrenia Families, $143,165; Tu, Benjamin, Johns Hopkins Univ./NIH, Networks, Pathways and Dynamics of Lysine Modification, $158,500; Vusirikala, Madhuri, Natl. Marrow Donor Program/NIH, RDSafe: Multicenter Study of Hematopoietic Stem Cell Donor Safety and Quality of Life, $1,000; Wetherington, Crista, Cincinnati Children’s Hosp./NIH, Promoting Treatment Adherence in Adolescent Leukemia, $97,927; Womack, Kyle, U.S. Dept. of Education, North Texas Traumatic Brain Injury Model Systems, $430,350; Womack, Kyle, Univ. of California, San Diego/NIH, ADNI-GO: Alzheimer’s Disease Neuroimaging Initiative Grand Opportunity – ARRA Stimulus Funding, $3,275; Wright, Woodring, Boston Biomed Research Inst./NIH, Biomarkers for Therapy of FSHD, $146,182; Yanagisawa, Masashi, Mount Sinai School of Medicine/NIH, Neural Substrates of Appetitive Behavior in Mood and Motivation – Project III, $61,239.
Non-Federal Awards – October 2011
Aquino, Victor, Children’s Healthcare of Atlanta, Allogeneic Hematopoietic Stem Cell Transplantation for Children and Adol with Severe Sickle Cell Disease: Pilot Study, $3,000; Chen, Benjamin, UT Arlington/CPRIT, C2; Live Cell Imaging Core, $47,812; Chiang, Cheng-Ming, UT M.D. Anderson/CPRIT, Molecular Mechanisms & Functions of Epigenetic Regulators; Project 2, $94,736; Eisch, Amelia, NARSAD, Adult Neurogenesis and Stress-Induced Social Avoidance, $50,000; Elias, Carol, Fndtn. For Prader-Willi Research, Role of Kiss1 Neurons in Mediating Ghrelin’s Effect on Reproduction and Metabolism, $50,000; Flores, Glenn, Children’s Med. Ctr. Dallas/Rees-Jones Fndtn., Innovative Intervention to Improve Health, Healthcare, and School Outcomes for Children in Foster Care, $95,000; Fontoura, Beatriz (M. Mata, Fellow), UT System, 2012 Jess Hay Chancellor’s Fellowship, $10,000; Haller, Ronald, CHDI Fndtn. Inc., Mitochondrial Stress Test: Validation Study in Subjects with Huntington’s Disease (HD) vs. Controls, $14,697.
Hill, Joseph, Cincinnati Children’s Hosp./Fondation Leducq, Proteotoxicity: Unappreciated Mechanism of Heart Disease and Its Potential for Novel Therapeutics, $119,000; Hooper, Lora (S. Vaishnava, Fellow), Crohn’s & Colitis Fndtn., Paneth Cell Specific Innate Immune Response to Intestinal Bacteria, $45,750; Idris, Ahamed, Univ. of Washington/American Heart Assn. Natl. Ctr., Continuation of Resuscitation Outcomes Consortium Registry – AHA, $53,779; Iyengar, Puneeth, Lung Cancer Research Fndtn., Comparative Genomics/Proteomics Approach with In Vivo Small Animal Validation for Developing Signature to Predict for Cachexia-Inducing Non-Small Cell Lung Cancers, $50,000; Kelly, Nancy, American Academy of Pediatrics, Transforming Pediatric Residency Training to Improve Care for Underserved Children, $20,000; Kurti, Laszlo, American Chemical Society, Novel Catalytic Enantioselective [3,3]-Sigmatropic Rearrangements for Preparation of Highly Substituted Fused Heterocycles and Biaryls, $50,000.
Monteggia, Lisa, Rett Syndrome Research Fndtn., Elucidation of Epigenetic Mechanisms in Rett Syndrome, $49,999; Olson, Eric, Fondation Leducq, Micro RNAs as Therapeutic Targets in Heart Failure, $457,801; Parada, Luis, Simons Fndtn., Mouse Models of Human ASDs: Gene Targeting in Specific Brain Regions, $400,000; Ross, Theodora, Burroughs Wellcome Fund, Abnormal HIP1 and Cancer Biology, $150,000; Rypma, Bart, Natl. Multiple Sclerosis Society, Hemodynamic Response Function Changes in Multiple Sclerosis, $159,154; Scherer, Philipp, UT Dallas/Juvenile Diabetes Research Fndtn., Non-Invasive Imaging Pancreatic Beta Cells Using Novel GLP-1 Constructs, $60,500; Schiller, Joan, Johns Hopkins Univ./American Assn. For Cancer Research, Ph2 Trial of Adjuvant Combin Epigenetic Therapy with 5-Azacitidine and Entinostat in Resected Stage I Non-Small Cell Lung Cancer vs. Standard Care, $4,000; Sperandio, Vanessa, Burroughs Wellcome Fund, Interkingdom Signaling in Bacterial Pathogenesis, $1,000.
Tambar, Uttam, American Chemical Society, Enantioselective Allylic Amination of Olefins, $50,000; Wang, Jing, UT M.D. Anderson/CPRIT, Advanced Volumetric Imaging and Adaptive Radiotherapy for Detecting and Correcting for Inter-Fractional Changes, $29,091; Willson, James K.V., American Cancer Society, Institutional Research Grant, $210,000; Yancey, Kim (D. Glass, Fellow), Skin of Color Society, Determining Genetic Causes of Keloid Formation, $15,000.
Industry Sponsored Awards, dollar amounts not available – October 2011
Brekken, Rolf, Evaluating Effect of Anti-TGFbRII Antibody on Progression of PDAC; Collins, Robert, Ph3 Study of Inotuzumab Ozogamicin and Rituximab in Subjects with CD22-Positive Aggressive Non-Hodgkin’s Lymphoma; Corey, David, Allele Selective Inhibition of Mutant Huntingtin by Single-Stranded Antisense Oligonucleotides; Gao, Fan, Comparative Biomechanical Efficacyacy of Vista Collar/CTO Orthoses; Garg, Abhimanyu, Lipodystrophy (LD) Database Research; Guleserian, Kristine, CRYOVALVE SG Aortic Human Heart Valve Cohort Study; Jain, Mamta, Study of Maraviroc with Other Antiretroviral Agents in HIV-1 Subjects with Hepatitis C and/or Hepatitis B Virus; Kenkel, Jeffrey, Evaluation of Ulthera System for Subjects who Failed to Respond to Previous Ultherapy vs. Subjects Naive to Ultherapy Treatment; Koh, Andrew, Protracted Colonization of Gastrointestinal Tract Leading to Disseminated Infection (Candida Albicans); Kutz, Joe, Ph2 Study of OTO-104 as Single, Intratypanic Injection in Subjects with Unilateral Meniere’s Disease.
Lavery, Lawrence, Study to Assess Efficacy and Safety of Nexagon in Treatment of Subjects with Venous Leg Ulcer; Lee, William, Oral Antivirals with Peginterferon Alfa 2a and Ribavirin in Treatment of Chronic Genotype 1 Hepatitis C Virus Infection; Lee, William, Study to Evaluate Different Regimens of MK-5172 When Admin with Peginterferon alfa-2b and Ribavirin in Treatment-Naive Patients with Chronic Genotype 1 Hepatitis C Virus Infection; Lotan, Yair, Surveillance of Low-Grade Non-Invasive Bladder Cancer Using Standard Follow-Up vs. Cystoscopy and NMP22 BladderChek Test; McPhaul, Michael, Compassionate Use Protocol for COROLUX in Treatment of Endogenous Cushing's Syndrome; Monson, Nancy, Can B Cells Present MBP to T Cells of MS Patients; Nasir, Dawood, Surgical Surveillance Trial to Evaluate Safety and Efficacy of Shortened Infusion Time of IV Ibuprofen; Petroll, Walter, Assessment of Corneal Epithelial Cell Viability Following Exposure to Ophthalmic Solutions.
Sarode, Venetia, Comparison of HEr2 Expression by Routine IHB and FISH in Patients with Invasive Breast Cancer – 2004-2009; Schiller, Joan, 2-Stage Study of Orally Admin BKM120 in Patients with Metastatic Non-Small Cell Lung Cancer with Activated P13K Pathway; Szmuk, Peter, IV Dosing of Buprenorphine in Pediatric Patients to 6 Yrs. Requiring Opioid Analgesia for Acute Moderate to Severe Pain; Torres, Fernando, DelIVery for Pulmonary Arterial Hypertension (PAH); Vusirikala, Madhuri, Ph3 Study of Vosaroxin and Cytarabine in Patients with Acute Myeloid Leukemia (VALOR).